Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2012; 18(42): 6076-6087
Published online Nov 14, 2012. doi: 10.3748/wjg.v18.i42.6076
Published online Nov 14, 2012. doi: 10.3748/wjg.v18.i42.6076
Figure 3 The in vitro release curve of nanoparticles in simulated body fluid (37 °C, pH 7.
4, n = 3). A rapid release was observed from time 0 h to 12 h, with a cumulative release percentage of 32.4%; a smooth slow-release occurred between day 1 and day 8, with a cumulative release percentage of 93.50%. During days 8 to 10, the release reached a plateau, with a cumulative release percentage of 95.70% at day 10.
- Citation: Cheng MR, Li Q, Wan T, He B, Han J, Chen HX, Yang FX, Wang W, Xu HZ, Ye T, Zha BB. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects. World J Gastroenterol 2012; 18(42): 6076-6087
- URL: https://www.wjgnet.com/1007-9327/full/v18/i42/6076.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i42.6076